161 related articles for article (PubMed ID: 21565192)
1. Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice.
Punga AR; Lin S; Oliveri F; Meinen S; Rüegg MA
Exp Neurol; 2011 Aug; 230(2):207-17. PubMed ID: 21565192
[TBL] [Abstract][Full Text] [Related]
2. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
3. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A
Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
[TBL] [Abstract][Full Text] [Related]
4. MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.
Punga AR; Maj M; Lin S; Meinen S; Rüegg MA
Eur J Neurosci; 2011 Mar; 33(5):890-8. PubMed ID: 21255125
[TBL] [Abstract][Full Text] [Related]
5. Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK+) experimental autoimmune Myasthenia gravis (EAMG).
Chauhan M; Punga T; Punga AR
Neurosci Res; 2013; 77(1-2):102-9. PubMed ID: 23933211
[TBL] [Abstract][Full Text] [Related]
6. Neurophysiological characteristics of MuSK antibody positive myasthenia gravis mice: focal denervation and hypersensitivity to acetylcholinesterase inhibitors.
Chroni E; Punga AR
J Neurol Sci; 2012 May; 316(1-2):150-7. PubMed ID: 22251934
[TBL] [Abstract][Full Text] [Related]
7. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
8. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
[TBL] [Abstract][Full Text] [Related]
9. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
10. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.
Niks EH; Kuks JB; Wokke JH; Veldman H; Bakker E; Verschuuren JJ; Plomp JJ
Muscle Nerve; 2010 Aug; 42(2):283-8. PubMed ID: 20544919
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis.
Mori S; Kubo S; Akiyoshi T; Yamada S; Miyazaki T; Hotta H; Desaki J; Kishi M; Konishi T; Nishino Y; Miyazawa A; Maruyama N; Shigemoto K
Am J Pathol; 2012 Feb; 180(2):798-810. PubMed ID: 22142810
[TBL] [Abstract][Full Text] [Related]
12. [Myasthenia gravis induced by autoantibodies against MuSK].
Shigemoto K; Konishi T; Ohta M
Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH
Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332
[TBL] [Abstract][Full Text] [Related]
14. Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS.
Meinen S; Lin S; Rüegg MA; Punga AR
PLoS One; 2012; 7(8):e44148. PubMed ID: 22952904
[TBL] [Abstract][Full Text] [Related]
15. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK.
Küçükerden M; Huda R; Tüzün E; Yılmaz A; Skriapa L; Trakas N; Strait RT; Finkelman FD; Kabadayı S; Zisimopoulou P; Tzartos S; Christadoss P
J Neuroimmunol; 2016 Jun; 295-296():84-92. PubMed ID: 27235354
[TBL] [Abstract][Full Text] [Related]
16. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.
Benveniste O; Jacobson L; Farrugia ME; Clover L; Vincent A
J Neuroimmunol; 2005 Dec; 170(1-2):41-8. PubMed ID: 16213598
[TBL] [Abstract][Full Text] [Related]
17. Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles.
Kuwabara S; Nemoto Y; Misawa S; Takahashi H; Kawaguchi N; Hattori T
Acta Neurol Scand; 2007 Feb; 115(2):126-8. PubMed ID: 17212617
[TBL] [Abstract][Full Text] [Related]
18. Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors.
Morsch M; Reddel SW; Ghazanfari N; Toyka KV; Phillips WD
Exp Neurol; 2012 Oct; 237(2):286-95. PubMed ID: 22789393
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase].
Maruyama N; Shigemoto K
Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813
[TBL] [Abstract][Full Text] [Related]
20. Denervation-related changes in acetylcholine receptor density and distribution in the rat flexor digitorum sublimis muscle.
Guzzini M; Raffa S; Geuna S; Nicolino S; Torrisi MR; Tos P; Battiston B; Grassi F; Ferretti A
Ital J Anat Embryol; 2008; 113(4):209-16. PubMed ID: 19507461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
